Development of pharmaceutical compositions based on animal and plant-derived squalene
Journal of Drug Delivery and Therapeutics · 15.06.2026 · 16 (6) · 1-10
DOI: 10.22270/jddt.v16i6.7577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery and Therapeutics, online erschienen am 15.06.2026. Verfasst von Maria M. Silaenkova und 7 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
This study aimed to develop and evaluate stable pharmaceutical compositions based on squalene derived from both animal (shark liver) and plant (amaranth oil) sources.
Methods
Oil-in-water nanoemulsions were prepared and stored at 4 °C for six months to evaluate stability. Key stability parameters, including droplet size and zeta potential, were determined using Dynamic Light Scattering (DLS). The immunogenicity of VLP-based rotavirus vaccine formulations containing these adjuvants was evaluated in a guinea pig model. Humoral and cellular immune responses were quantified using Enzyme-Linked Immunosorbent Assay (ELISA) for IgG titers, Neutralization Assays (NA) for virus-neutralizing activity, and the Lymphocyte Blast Transformation Reaction (LBTR) to assess cell-mediated immunity.
Results
Both formulations exhibited high stability at 4 °C. Mean droplet diameters were 157 ± 3 nm (animal-derived) and 149 ± 3 nm (plant-derived), which were smaller than the commercial reference (174 ± 4 nm). Zeta potential values (-35 to -39 mV) confirmed robust colloidal stability. Immunization elicited potent responses; no statistically significant differences were observed between the two squalene sources regarding specific IgG titers (GM = 126 267) or virus-neutralizing activity (VNA GM = 640 vs 452.5, p > 0.05). Cellular immunity was induced by both adjuvants, yielding Proliferation Stimulation Index (PSI) values of 3.11 for the plant-derived formulation and 2.10 for the animal-derived variant.
Conclusion
Plant-derived squalene from amaranth oil is a highly effective, sustainable alternative to shark-derived components, providing comparable stability and immunogenic potency for vaccine delivery. Keywords: pharmaceutical compositions, adjuvants, squalene, amaranth oil, nanoemulsions, virus-like particles, VLPs, vaccine formulations.
Zitieren
APA
Silaenkova, M. M., Garaev, T. M., Yudin, I. I., Ledenev, O. V., Eliseeva, O. V., Latyshev, O. E., Syroeshkin, A. V., & Grebennikova, T. V. (2026). Development of pharmaceutical compositions based on animal and plant-derived squalene. Journal of Drug Delivery and Therapeutics, 16(6), 1-10. https://doi.org/10.22270/jddt.v16i6.7577
Vancouver
Silaenkova MM, Garaev TM, Yudin II, Ledenev OV, Eliseeva OV, Latyshev OE, et al. Development of pharmaceutical compositions based on animal and plant-derived squalene. Journal of Drug Delivery and Therapeutics. 2026;16(6):1-10. doi:10.22270/jddt.v16i6.7577
BibTeX
@article{Silaenkova2026,
author = {Silaenkova, Maria M. and Garaev, Timur M. and Yudin, Ilya I. and Ledenev, Oleg V. and Eliseeva, Olesya V. and Latyshev, Oleg E. and Syroeshkin, Anton V. and Grebennikova, Tatyana V.},
title = {Development of pharmaceutical compositions based on animal and plant-derived squalene},
journal = {Journal of Drug Delivery and Therapeutics},
year = {2026},
volume = {16},
number = {6},
pages = {1--10},
doi = {10.22270/jddt.v16i6.7577}
}
EUVIMED